| Mehmet Oz, President-elect Donald Trump’s pick to run CMS, has extolled Ozempic’s promise for weight loss. Now he could play a key role in the decision on whether to expand coverage for the costly, life-changing drug to millions of Medicare and Medicaid beneficiaries. | 
